|
⚲
|
| Keyboard |
| Axon Steven
✚
|
|
|---|---|
| CIK # | 0001720605 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001720605] | |
| 4 | [0001720605] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Axon Steven | |
| Apellis Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2018-11-14 | Option exercise | 11,500 | $2.59 | 29,785 |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (Right to Buy) · derivative
|
2018-11-14 | Option exercise | 11,500 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2018-02-20 | Option exercise | 38,610 | $2.59 | 100,000 |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (right to buy) · derivative
|
2018-02-20 | Option exercise | 38,610 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (right to buy) · derivative
|
2018-02-16 | Grant | 60,000 | $0.00 |